ENDEAVOR BIOMEDICINES, INC.

Profile

Company Names

ENDEAVOR BIOMEDICINES, INC.

Addresses

12707 HIGH BLUFF DRIVE, SUITE 300, SAN DIEGO, CA 92130

12707 HIGH BLUFF DR., SUITE 300, SAN DIEGO, CA 92130

Phone Numbers

(858) 537-1700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$221,703,239.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-04-22 
$132,583,908.00 
$132,583,908.00 
$0.00 
Equity 
1
2022-01-21 
$89,119,331.00 
$100,999,983.00 
$11,880,652.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BERNARD 
 
DAVITIAN 
DIRECTOR
PROTEOSTASIS THERAPEUTICS, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  VANQUA BIO, INC.   |  ENDEAVOR BIOMEDICINES, INC.
MIGUEL 
 
DE LOS RIOS 
EXECUTIVE OFFICER
CHIMEROS INC   |  RIFT BIOTHERAPEUTICS, INC.   |  ENDEAVOR BIOMEDICINES, INC.
PATRICK 
G. 
ENRIGHT 
DIRECTOR
JAZZ PHARMACEUTICALS INC   |  CORCEPT THERAPEUTICS INC   |  ESPERION THERAPEUTICS, INC.   |  CARDIODX INC   |  APTINYX INC.   |  AIMMUNE THERAPEUTICS, INC.   |  ENDEAVOR BIOMEDICINES, INC.
JOHN 
 
HOOD 
DIRECTOR, EXECUTIVE OFFICER
ENDEAVOR BIOMEDICINES, INC.
ENOCH 
 
KARIUKI 
EXECUTIVE OFFICER
ENDEAVOR BIOMEDICINES, INC.
CHRIS 
 
KRUEGER 
EXECUTIVE OFFICER
VINETI, INC.   |  STRATEOS, INC.   |  ENDEAVOR BIOMEDICINES, INC.
WING 
CHEONG 
LAM 
DIRECTOR
ENDEAVOR BIOMEDICINES, INC.
MONAL 
 
MEHTA 
DIRECTOR
ENDEAVOR BIOMEDICINES, INC.   |  858 THERAPEUTICS, INC.
RAGHU 
 
SARIPALLI 
EXECUTIVE OFFICER
ENDEAVOR BIOMEDICINES, INC.
KARAN 
 
TAKHAR 
DIRECTOR
PALLEON PHARMACEUTICALS INC.   |  VELOSBIO INC.   |  AURA BIOSCIENCES, INC.   |  BARDAVON HEALTH INNOVATIONS, INC.   |  MONOD BIO, INC.   |  ENDEAVOR BIOMEDICINES, INC.
VISHAAL 
 
TURAKHIA 
EXECUTIVE OFFICER
ENDEAVOR BIOMEDICINES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-04-22 
2022-02-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#